Rx Frontier Afrika
For 54gene — the Nigerian genomics startup that raised forty-five million dollars before winding down in 2023 — the popular story has two versions. Version one: a frontier-market bet that got ahead of itself, with a founder who misread the room. Version two: a visionary scientist pushed out by predatory investors who stripped the company for parts. Both versions are incomplete. And on Per Visum, incomplete is not good enough.
2 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Rx Frontier Afrika!